FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martina Fabris

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Enzyme-Linked Immunosorbent Assay

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Luca Quartuccio; Sara Salvin; Martina Fabris; Miriam Isola; Marta Maset; Elena Pontarini; Salvatore De Vita
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.
Martina Fabris; Fabio Fischetti; Federico Fogolari; Marcello Govoni; Mariangela Manfredi; Pia Morassi; Raffaele Pellerito; Elena Pontarini; Luca Quartuccio; Viviana Ravagnani; Sara Salvin; Marta Saracco; Piercarlo Sarzi Puttini; Franco Schiavon; Angelo Semeraro; Elio Tonutti; Ed Vital; Alen Zabotti; Fabiola Atzeni; Laura Bazzicchi; Maurizio Benucci; Domenico Biasi; Stefano Bombardieri; Roberto Bortolotti; Roberto Caporali; Valeria Carraro; Marco Cimmino; Paul Emery; Cinzia Fabro; Salvatore De Vita
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.
Salvatore De Vita; Luca Quartuccio; Sara Salvin; Alen Zabotti; Laura Corazza; Martina Fabris
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martina Fabris (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Luca Quartuccio; Sara Salvin; Martina Fabris; Miriam Isola; Marta Maset; Elena Pontarini; Salvatore De Vita
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.
Rheumatology (Oxford, England) 2013;52(2):276-81.
2013: Martina Fabris; Fabio Fischetti; Federico Fogolari; Marcello Govoni; Mariangela Manfredi; Pia Morassi; Raffaele Pellerito; Elena Pontarini; Luca Quartuccio; Viviana Ravagnani; Sara Salvin; Marta Saracco; Piercarlo Sarzi Puttini; Franco Schiavon; Angelo Semeraro; Elio Tonutti; Ed Vital; Alen Zabotti; Fabiola Atzeni; Laura Bazzicchi; Maurizio Benucci; Domenico Biasi; Stefano Bombardieri; Roberto Bortolotti; Roberto Caporali; Valeria Carraro; Marco Cimmino; Paul Emery; Cinzia Fabro; Salvatore De Vita
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.
Arthritis and rheumatism 2013;65(1):88-97.
2012: Salvatore De Vita; Luca Quartuccio; Sara Salvin; Alen Zabotti; Laura Corazza; Martina Fabris
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
Rheumatology (Oxford, England) 2012;51(4):627-33.
2012: Martina Fabris; Cinzia Fabro; Fabio Fischetti; Marcello Govoni; Sandra Lombardi; Mariangela Manfredi; Pia Morassi; Melissa Padovan; Raffaele Pellerito; Elena Pontarini; Luca Quartuccio; Marta Saracco; Piercarlo Sarzi Puttini; Elio Tonutti; Fabiola Atzeni; Lisa Maria Bambara; Maurizio Benucci; Antonio Carletto; Marco Cimmino; Francesco Curcio; Maurizio Cutolo; Salvatore De Vita
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis.
Autoimmunity reviews 2012;11(5):315-20.
2010: Martina Fabris; Luca Quartuccio; S Lombardi; M Benucci; M Manfredi; M Saracco; F Atzeni; P Morassi; M A Cimmino; E Pontarini; C Fabro; R Pellerito; Piercarlo Sarzi-Puttini; M Cutolo; A Carletto; L M Bambara; F Fischetti; F Curcio; E Tonutti; Salvatore De Vita
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis.
Reumatismo 2010;62(4):253-8.
2010: Martina Fabris; F Grimaldi; D Villalta; A Picierno; C Fabro; M Bolzan; Salvatore De Vita; Elio Tonutti
BLyS and April serum levels in patients with autoimmune thyroid diseases.
Autoimmunity reviews 2010;9(3):165-9.
2009: Martina Fabris; Salvatore De Vita; Daniela Visentini; Cinzia Fabro; Alessia Picierno; Alice Lerussi; Danilo Villalta; Maria Grazia Alessio; Marilina Tampoia; Elio Tonutti
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease.
Annals of the New York Academy of Sciences 2009;1173():268-73.
2009: Luca Quartuccio; S Salvin; M Saracco; S Lombardi; Martina Fabris; E Mansutti; M Maset; S Pellerito; Salvatore De Vita
[Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis].
Reumatismo 2009;61(3):182-6.
2009: Luca Quartuccio; Martina Fabris; Sara Salvin; Marta Maset; Ginevra De Marchi; Salvatore De Vita
Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation.
International journal of rheumatology 2009;2009():424935.
2008: Martina Fabris; Luca Quartuccio; S Salvin; Gabriele Pozzato; Valli De Re; Cesare Mazzaro; Clodoveo Ferri; Chiara Baldini; Salvatore De Vita
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia.
Annals of the rheumatic diseases 2008;67(1):80-3.
2007: Martina Fabris; Daniela Visentini; Valli De Re; Alessia Picierno; Roberto Maieron; Renato Cannizzaro; Danilo Villalta; Francesco Curcio; Salvatore De Vita; Elio Tonutti
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease.
Scandinavian journal of gastroenterology 2007;42(12):1434-9.
2007: Luca Quartuccio; Martina Fabris; S Salvin; Miriam Isola; Franca Soldano; Edmondo Falleti; Carlo Alberto Beltrami; Valli De Re; Salvatore De Vita
Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis.
Rheumatology (Oxford, England) 2007;46(11):1657-61.
2007: Salvatore De Vita; Luca Quartuccio; Martina Fabris
Rituximab in mixed cryoglobulinemia: increased experience and perspectives.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2007;39 Suppl 1():S122-8.
2007: Luca Quartuccio; Ginevra De Marchi; Martina Fabris; Salvatore De Vita
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication.
Rheumatology (Oxford, England) 2007;46(2):367-8.
2007: Martina Fabris; Luca Quartuccio; Stefania Sacco; Ginevra De Marchi; Gabriele Pozzato; Cesare Mazzaro; Gianfranco Ferraccioli; T S Migone; Salvatore De Vita
B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.
Rheumatology (Oxford, England) 2007;46(1):37-43.
2006: Luca Quartuccio; Giorgio Soardo; G Romano; Francesco Zaja; Cathryn Anne Scott; Ginevra De Marchi; Martina Fabris; Gianfranco Ferraccioli; Salvatore De Vita
Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
Rheumatology (Oxford, England) 2006;45(7):842-6.
2006: Valli De Re; Domenico Sansonno; Maria Paola Simula; Laura Caggiari; Daniela Gasparotto; Martina Fabris; Felicia Anna Tucci; Vito Racanelli; R Talamini; Mara Campagnolo; Silvano Geremia; Franco Dammacco; Salvatore De Vita
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations.
Leukemia 2006;20(6):1145-54.
2006: Valli De Re; Salvatore De Vita; Domenico Sansonno; Daniela Gasparotto; Maria Paola Simula; Felicia Anna Tucci; Alessandra Marzotto; Martina Fabris; Annunziata Gloghini; Antonino Carbone; Franco Dammacco; Mauro Boiocchi
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.
Rheumatology (Oxford, England) 2006;45(6):685-93.
2006: Luca Quartuccio; Valli De Re; Martina Fabris; Alessandra Marzotto; Nicoletta Franzolini; Daniela Gasparotto; Laura Caggiari; Gianfranco Ferraccioli; Cathryn Anne Scott; Salvatore De Vita
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
Haematologica 2006;91(5):691-4.
2005: Martina Fabris; Barbara Tolusso; Emma Di Poi; Paola Tomietto; Stefania Sacco; Elisa Gremese; Gianfranco Ferraccioli
Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression.
The Journal of rheumatology 2005;32(6):998-1005.
2005: Barbara Tolusso; Martina Fabris; Roberto Caporali; Giovanna Cuomo; Miriam Isola; Franca Soldano; Carlomaurizio Montecucco; Gabriele Valentini; Gianfranco Ferraccioli
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis.
Immunology letters 2005;96(1):103-8.
2004: Luca Quartuccio; Martina Fabris; Gianfranco Ferraccioli
[B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis].
Reumatismo 2004;56(3):143-6.
2004: Martina Fabris; Barbara Tolusso; Elisa Gremese; Paola Tomietto; Gianfranco Ferraccioli
[Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients peripheral blood mononuclear cells stimulated with lipopolysaccharide].
Reumatismo 2004;56(2):94-103.
2004: Ginevra De Marchi; Salvatore De Vita; Martina Fabris; Cathryn Anne Scott; Gianfranco Ferraccioli
Systemic connective tissue disease complicated by Castleman's disease: report of a case and review of the literature.
Haematologica 2004;89(4):ECR03.
2003: Barbara Tolusso; Martina Fabris; Elisa Gremese; M Mosca; Patrizia Rovere-Querini; Gianfranco F Ferraccioli
Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association.
Annals of the rheumatic diseases 2003;62(8):781-2.
2003: Barbara Tolusso; Martina Fabris; Emma Di Poi; Roberta Assaloni; Paola Tomietto; Gianfranco F Ferraccioli
Response of mononuclear cells to lipopolysaccharide and CpG oligonucleotide stimulation: possible additive effect in rheumatoid inflammation.
Annals of the rheumatic diseases 2003;62(3):284-5.
2002: Gianfranco F Ferraccioli; Roberta Assaloni; Emma Di Poi; Elisa Gremese; Ginevra De Marchi; Martina Fabris
Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.
Rheumatology (Oxford, England) 2002;41(10):1109-12.
2002: Martina Fabris; Barbara Tolusso; Emma Di Poi; Roberta Assaloni; Luigi Sinigaglia; Gianfranco Ferraccioli
Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
The Journal of rheumatology 2002;29(9):1847-50.
2002: Gianfranco Ferraccioli; F Mecchia; Emma Di Poi; Martina Fabris
Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections.
Annals of the rheumatic diseases 2002;61(4):358-61.
2002: Martina Fabris; Emma Di Poi; Stefania Sacco; Giuseppe Damante; Luigi Sinigaglia; Gianfranco Ferraccioli
[TNF- alpha gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-alpha agents: preliminary results].
Reumatismo 2002;54(1):19-26.
2002: Martina Fabris; Emma Di Poi; Angela Valentina D'Elia; Giuseppe Damante; Luigi Sinigaglia; Gianfranco Ferraccioli
Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis.
The Journal of rheumatology 2002;29(1):29-33.
2001: Salvatore De Vita; Ginevra De Marchi; Stefania Sacco; Elisa Gremese; Martina Fabris; Gianfranco Ferraccioli
Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.
Blood cells, molecules & diseases 2001;27(4):757-66.